Live Breaking News & Updates on Zydus lifesciences share price

Stay informed with the latest breaking news from Zydus lifesciences share price on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Zydus lifesciences share price and stay connected to the pulse of your community

MSCI May rejig to trigger $3.2 billion inflows into 17 stocks

MSCI will announce the changes in constituents of the MSCI global standard indices on May 14, while the changes will take place on May 31.

Msci , Msci-rejig , Zydus-lifesciences-share-price , Inflows , Iifl-securities , Pb-fintech , Stock-inclusion , Zydus-lifesciences , Paytm , Jsw-energy , Sundaram-finance

Zydus gets USFDA's nod for antipsychotic drug, stock flat

Pimavanserin is an atypical antipsychotic indicated for the treatment of hallucinations and delusions associated with Parkinson disease psychosis.

Ahmedabad , Gujarat , India , United-states , Zydus-lifesciences , Drug-administration , Cpc-income-tax-department , United-states-food , Pimavanserin-capsules , Pimavanserin-tablets , Zydus-life , Income-tax-department

zydus lifesciences share price: Fundamental Radar: Why Zydus Lifesciences is poised for strong earnings growth

Headquartered in Ahmedabad, Zydus Lifesciences is present across the pharmaceutical value chain of research, development, manufacturing, marketing, and sale of finished dosage human formulations, active pharmaceutical ingredients (APIs), animal healthcare products, and consumer wellness products.

Mumbai , Maharashtra , India , Zydus-lifesciences , Cadila-healthcare , Zydus-lifesciences-shares , Zydus-lifesciences-share-price , Zydus , Sodani , Mylab-discovery-solutions-for-rs ,

Zydus Lifesciences gains 5% on USFDA nod for cancer drug

The plerixafor injection, used by patients with certain types of cancer to prepare them for a stem cell transplant, will be manufactured at the group’s facility in Ahmedabad

United-states , Ahmedabad , Gujarat , India , American , Zydus-lifesciences , Bayer-zydus-pharma-private , National-stock-exchange , United-states-food , Zydus-pharma-private-limited , South-east-asia , Zydus-lifesciences-share-price